<unk>  has unique J shaped or anchor locked domain structure because of which it has a potent inhibition of DPP 4 enzyme.<unk>  significantly controls glycemic parameters with safety. No dose adjustment is required in renally impaired patients.
Teneligliptin
Linagliptin
Vildagliptin
Sitagliptin
Saxagliptin
Alogliptin
Liraglutide
Pioglitazone